China Medicine Statistics
Total Valuation
China Medicine has a market cap or net worth of 956,569.
| Market Cap | 956,569 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
China Medicine has 23.91 million shares outstanding.
| Current Share Class | 23.91M |
| Shares Outstanding | 23.91M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -1.00% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.01 |
| PB Ratio | 0.01 |
| P/TBV Ratio | 0.02 |
| P/FCF Ratio | 0.15 |
| P/OCF Ratio | 0.09 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.15, with a Debt / Equity ratio of 0.03.
| Current Ratio | 11.15 |
| Quick Ratio | 2.97 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.30 |
| Debt / FCF | 0.63 |
| Interest Coverage | 51.79 |
Financial Efficiency
Return on equity (ROE) is 6.63% and return on invested capital (ROIC) is 8.15%.
| Return on Equity (ROE) | 6.63% |
| Return on Assets (ROA) | 7.82% |
| Return on Invested Capital (ROIC) | 8.15% |
| Return on Capital Employed (ROCE) | 9.32% |
| Revenue Per Employee | 234,004 |
| Profits Per Employee | -403 |
| Employee Count | 281 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 6.33 |
Taxes
In the past 12 months, China Medicine has paid 3.76 million in taxes.
| Income Tax | 3.76M |
| Effective Tax Rate | 39.66% |
Stock Price Statistics
The stock price has increased by +19,900.00% in the last 52 weeks. The beta is 213.69, so China Medicine's price volatility has been higher than the market average.
| Beta (5Y) | 213.69 |
| 52-Week Price Change | +19,900.00% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 82.68 |
| Average Volume (20 Days) | 41,195 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.78 |
Income Statement
In the last 12 months, China Medicine had revenue of 65.76 million and -113,323 in losses. Loss per share was -0.01.
| Revenue | 65.76M |
| Gross Profit | 22.00M |
| Operating Income | 11.71M |
| Pretax Income | 9.48M |
| Net Income | -113,323 |
| EBITDA | 13.41M |
| EBIT | 11.71M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 7.85 million in cash and 4.05 million in debt, giving a net cash position of 3.81 million or 0.16 per share.
| Cash & Cash Equivalents | 7.85M |
| Total Debt | 4.05M |
| Net Cash | 3.81M |
| Net Cash Per Share | 0.16 |
| Equity (Book Value) | 125.52M |
| Book Value Per Share | 1.97 |
| Working Capital | 85.75M |
Cash Flow
In the last 12 months, operating cash flow was 11.01 million and capital expenditures -4.58 million, giving a free cash flow of 6.43 million.
| Operating Cash Flow | 11.01M |
| Capital Expenditures | -4.58M |
| Free Cash Flow | 6.43M |
| FCF Per Share | 0.27 |
Margins
Gross margin is 33.46%, with operating and profit margins of 17.80% and 9.17%.
| Gross Margin | 33.46% |
| Operating Margin | 17.80% |
| Pretax Margin | 14.42% |
| Profit Margin | 9.17% |
| EBITDA Margin | 20.39% |
| EBIT Margin | 17.80% |
| FCF Margin | 9.78% |
Dividends & Yields
China Medicine does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -107.86% |
| Shareholder Yield | -107.86% |
| Earnings Yield | -11.85% |
| FCF Yield | 672.24% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
China Medicine has an Altman Z-Score of 5.8 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.8 |
| Piotroski F-Score | 5 |